TAMH
CRNX icon

Taikang Asset Management (HK)’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,500
Closed -$285K 103
2025
Q1
$285K Hold
8,500
0.04% 100
2024
Q4
$435K Hold
8,500
0.06% 98
2024
Q3
$434K Hold
8,500
0.05% 100
2024
Q2
$381K Buy
+8,500
New +$381K 0.06% 94